During the past decade, Hôpital Belle Isle conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hôpital Belle Isle" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "ALK Gene Mutation" (1 trials), "BRAF Gene Mutation" (1 trials), "Colorectal Neoplasms" (1 trials) and "KRAS Gene Mutation" (1 trials). Many other conditions were trialed in "Hôpital Belle Isle" in a lesser frequency.

Most popular intervention types in "Hôpital Belle Isle" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "5 FU bolus" (1 trials), "5 FU continuous" (1 trials), "Bevacizumab" (1 trials), "Customized Treatment" (1 trials) and "Folinic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Belle Isle" are 5 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpital Belle Isle". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Hôpital Belle Isle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Belle Isle, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".